DekaBank Deutsche Girozentrale grew its position in Xylem Inc. (NYSE:XYL - Free Report) by 1.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,656,369 shares of the industrial products company's stock after buying an additional 27,880 shares during the period. DekaBank Deutsche Girozentrale owned approximately 0.68% of Xylem worth $213,108,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in XYL. Valley National Advisers Inc. grew its holdings in shares of Xylem by 84.9% in the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after buying an additional 101 shares during the period. Maseco LLP acquired a new position in Xylem in the 2nd quarter worth $31,000. Center for Financial Planning Inc. boosted its stake in Xylem by 52.0% in the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after purchasing an additional 91 shares during the period. ST Germain D J Co. Inc. boosted its stake in Xylem by 950.0% in the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock worth $33,000 after purchasing an additional 228 shares during the period. Finally, Headlands Technologies LLC boosted its stake in Xylem by 90.6% in the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock worth $36,000 after purchasing an additional 145 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.
Insider Transactions at Xylem
In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares in the company, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.27% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on the stock. Cowen reaffirmed a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. Barclays assumed coverage on shares of Xylem in a research note on Friday, September 19th. They issued an "overweight" rating and a $165.00 target price for the company. Stifel Nicolaus upped their target price on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Citigroup upped their target price on shares of Xylem from $168.00 to $173.00 and gave the stock a "buy" rating in a research note on Thursday, October 9th. Finally, Weiss Ratings reissued a "buy (b)" rating on shares of Xylem in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $154.67.
View Our Latest Report on Xylem
Xylem Trading Up 0.6%
Shares of NYSE:XYL opened at $146.76 on Tuesday. The company's 50-day moving average price is $143.39 and its two-hundred day moving average price is $131.73. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a one year low of $100.47 and a one year high of $151.16. The stock has a market capitalization of $35.72 billion, a PE ratio of 38.12, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. The firm had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company's revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, equities analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date was Thursday, August 28th. Xylem's dividend payout ratio (DPR) is 41.56%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.